Geoffrey M. Nichol

2014

In 2014, Geoffrey M. Nichol earned a total compensation of $1.8M as Former Executive Vice President, Research and Development at Sangamo Biosciences, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$186,300
Option Awards$607,343
Salary$460,000
Stock Awards$527,625
Total$1,781,268

Nichol received $607.3K in option awards, accounting for 34% of the total pay in 2014.

Nichol also received $186.3K in non-equity incentive plan, $460K in salary and $527.6K in stock awards.

Rankings

In 2014, Geoffrey M. Nichol's compensation ranked 4,995th out of 13,032 executives tracked by ExecPay. In other words, Nichol earned more than 61.7% of executives.

ClassificationRankingPercentile
All
4,995
out of 13,032
62nd
Division
Manufacturing
1,781
out of 4,966
64th
Major group
Chemicals And Allied Products
588
out of 1,686
65th
Industry group
Drugs
448
out of 1,365
67th
Industry
Biological Products, Except Diagnostic Substances
75
out of 236
68th
Source: SEC filing on April 25, 2017.

Nichol's colleagues

We found four more compensation records of executives who worked with Geoffrey M. Nichol at Sangamo Biosciences in 2014.

2014

Edward Lanphier

Sangamo Biosciences

Chief Executive Officer

2014

Philip Gregory

Sangamo Biosciences

Chief Scientific Officer

2014

H Wolff

Sangamo Biosciences

Chief Financial Officer

2014

Dale Ando

Sangamo Biosciences

Chief Medical Officer

You may also like